These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1440407)

  • 21. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term percutaneous therapy of angina pectoris with isosorbide dinitrate with reference to isosorbide dinitrate blood levels].
    Kriehuber E; Prey T; Orthofer R
    Wien Med Wochenschr; 1982 Jun; 132(12):295-302. PubMed ID: 7123974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
    Joseph G
    Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
    [No Abstract]   [Full Text] [Related]  

  • 24. Can the problem of nitrate tolerance be solved?
    Silber S
    Z Kardiol; 1985; 74 Suppl 1():51-4. PubMed ID: 3993162
    [No Abstract]   [Full Text] [Related]  

  • 25. [ECG clinical trial with an antianginal drug (author's transl)].
    Fernandez Garcia JJ; Sánchez de la Cuesta y Alarcón F; Tallón-Cantero R; Martínez Rangel F; Bermudo Fernández L; Tallón Moreno R; Garrigo Toro A; de Lis Morales J
    Folia Clin Int (Barc); 1976 Jan; 26(1):49-55. PubMed ID: 976530
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molsidomine and isosorbide dinitrate: a comparative trial of tolerance in long-term intake by IHD patients with stable angina of effort].
    Alimova EV; Martsevich SIu; Kutishenko NP; Metelitsa VI
    Ter Arkh; 1997; 69(12):37-40. PubMed ID: 9503532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
    Thadani U
    Herz; 1984 Jun; 9(3):123-36. PubMed ID: 6430766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Duration of effects of isosorbide dinitrate retard in coronary disease].
    Raab C; Schindler J; Rahlfs VW
    Med Welt; 1977 Nov; 28(44):1807-9. PubMed ID: 593121
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of isosorbide dinitrate (isoket) in stenocardia and myocardial infarction].
    Polotskaia EL; Akopian LM; Karavaeva IP; Semenova LA; Krasina GF
    Klin Med (Mosk); 1985 Aug; 63(8):36-41. PubMed ID: 3908808
    [No Abstract]   [Full Text] [Related]  

  • 32. [Exercise test in the evaluation of effectiveness of 4 antianginal drugs (author's transl)].
    Figini A; De Ponti C; Campolo L
    G Ital Cardiol; 1974; 4(3):289-95. PubMed ID: 4152383
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
    Demchenko EA; Berezina AV; Panov AV
    Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
    [No Abstract]   [Full Text] [Related]  

  • 34. [Continuous infusion of isosorbide dinitrate in intractable rest angina pectoris: report of a case].
    Fujii K; Tauchi M; Hoshida S; Kagiya T; Ozaki H; Mishima M; Kitabatake A; Inoue M; Kamata T
    J Cardiol Suppl; 1989; 22():17-9. PubMed ID: 2640861
    [No Abstract]   [Full Text] [Related]  

  • 35. [Iso Mack Retard 40 mg. Coronary drug for long term therapy and prophylaxis in coronary circulation disorders (angina pectoris)].
    Wien Klin Wochenschr; 1980 Oct; 92(19):695-6. PubMed ID: 7467343
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ergometric evaluation of the efficacy of a delayed-action nitroderivative].
    Vajola SF; Boccardi L; Cacciatore G; Minardi G; Pozzar F; Schiavo B
    Boll Soc Ital Cardiol; 1981; 26(11):1417-20. PubMed ID: 7349184
    [No Abstract]   [Full Text] [Related]  

  • 37. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dosage isosorbide dinitrate therapy for angina.
    Tremblay G; Biron P; Désourdy F
    Can Med Assoc J; 1983 Mar; 128(6):679-81. PubMed ID: 6825033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double blind test about the effect of Isoket retard on the exercise tolerance respectively the hypoxia of the myocardium by ergometrical determination (author's transl)].
    Böhm H; Ludwig B; Scala G; Stegu E; Torabizadeh A
    Schweiz Rundsch Med Prax; 1979 Mar; 68(12):385-9. PubMed ID: 432204
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical use of potassium channel activators in angina pectoris: efficacy and tolerance].
    Specchia G; Marsico F; Micheletti T; Bona M
    Cardiologia; 1995 Dec; 40(12 Suppl 1):91-5. PubMed ID: 8998788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.